Health-care companies rose amid optimism about pharmaceutical sales.
Shares of Pyxis Oncology fell sharply after the cancer drug developer said it would likely harvest initial data from its lead program in the fall.
Some Medicare members could get help paying for the popular new weight-loss drug Wegovy, as long as they have a history of heart disease and are using it to prevent recurring heart attacks and strokes, The Wall Street Journal reported. Shares of Wegovy maker Novo Nordisk were flat.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-21-24 1745ET
